- COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
-
Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
- -
-
Page/Page column 54
(2019/04/11)
-
- COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
-
Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treati
- -
-
Page/Page column 54
(2015/12/23)
-
- METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
-
Compounds and compositions are described herein for treating post tramatic stress disorder.
- -
-
Page/Page column 46
(2012/01/15)
-
- BETA-LACTAM CANNABINOID RECEPTOR MODULATORS
-
Described herein are substituted 2-(azetidin-2-on-l-yl)alkanoic acids, alkanedioic acids and 2-hydroxyalkyl alkanoic acids, and 2-acyl alkanoic acids, and derivatives thereof, that are capable of modulating activity at the cannabinoid-1 (CBl) and/or canna
- -
-
Page/Page column 84-85
(2008/06/13)
-
- β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
-
β-lactamyl alkanoic acids and pharmaceutical compositions thereof are described. Methods for treating various diseases and disease states using one or more β-lactamyl alkanoic acids are also described. Substituted 2-(azetidin-2-on-l-yl)alkanedioic acids,
- -
-
Page/Page column 63
(2010/11/28)
-
- HYDROXY AND KETO-SUBSTITUTED β-LACTAMYL ALKANEDIOIC ACIDS
-
3-Hydroxy and 3-keto substituted 2-(azetidin-2-on-l-yl)alkanedioic acids, and analogs and derivatives thereof are described. Methods for using 3-hydroxy and 3-keto substituted 2-(azetidin-2-on-l-yl)alkanedioic acids, and analogs and derivatives thereof, i
- -
-
Page/Page column 48
(2010/11/28)
-
- BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS
-
0-lactamyl alkanoic acids are described. Methods for treating various premenstrual disorders using or more β-lactamyl alkanoic acids are also described.
- -
-
Page/Page column 22
(2008/06/13)
-
- 3-SUBSTITUTED β-LACTAMYL VASOPRESSIN V1A ANTAGONISTS
-
Novel 2-(azetidin-2-on-1-yl)alkanedioic acids and derivatives thereof are described. Methods for using 2-(azetidin-2-on-l-yl)alkanedioic acids and derivatives thereof in the treatment of disease states responsive to antagonism of the vasopressin V1a
- -
-
Page/Page column 40-41
(2008/06/13)
-